37.0% of #$PVLA volume traded off-exchange, vs a 40.4% average over the prior 4 sessions.
Big-block activity is cooling: price is being set on the lit market.
Full story at the link.
#darkpool #stocks #stockmarket
37.0% of #$PVLA volume traded off-exchange, vs a 40.4% average over the prior 4 sessions.
Big-block activity is cooling: price is being set on the lit market.
Full story at the link.
#darkpool #stocks #stockmarket
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-to-host-webcast-to-introduce-new-qtorintm-l5azqifeoeaq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-to-host-webcast-to-introduce-new-qtorintm-l5azqifeoeaq.html?utm_source=stocktitan-bluesky&utm_medium=social
SOLD: 1,449 shares @ $164.85
Total: $239K
Trade date Nov 10, 2026
📈 History & trend → https://www.formdelta.com/ticker/PVLA
#InsiderTrading #PVLA #StockMarket
SOLD: 1,449 shares @ $164.85
Total: $239K
Trade date Nov 10, 2026
📈 History & trend → https://www.formdelta.com/ticker/PVLA
#InsiderTrading #PVLA #StockMarket
#$PVLA options tape: calls $157K, puts $32K (total $189K) (83% calls).
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Full story at the link.
#darkpool #stocks #stockmarket
#$PVLA options tape: calls $157K, puts $32K (total $189K) (83% calls).
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Full story at the link.
#darkpool #stocks #stockmarket
JEFFREY MARTINI, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $8,704,000.00, on 11/10/2026.
JEFFREY MARTINI, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $8,704,000.00, on 11/10/2026.
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Read the full article for the full details.
#darkpool #stocks #fintwit
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Read the full article for the full details.
#darkpool #stocks #fintwit
FISV, PCOR, AHR, IBN, STE, SNY, RYAN, YUMC, HTHT, AMX, TM, COLD, SHLS, LION, PVLA, PAC, PHG, SUZ, VCEL, CWT, HLF, ESRT
FISV, PCOR, AHR, IBN, STE, SNY, RYAN, YUMC, HTHT, AMX, TM, COLD, SHLS, LION, PVLA, PAC, PHG, SUZ, VCEL, CWT, HLF, ESRT
https://fundspec.ai/s/PVLA/earnings
Watchlists that sync across every device you own.
https://fundspec.ai/s/PVLA/earnings
Watchlists that sync across every device you own.
On November 5, 2026, the Company will hold its earnings call and use a slide presentation in conjunction with the earnings call.
On November 5, 2026, the Company will hold its earnings call and use a slide presentation in conjunction with the earnings call.
Daily Wrap - Final Message: Daily Wrap up for 2026-11-06 - 4557 events.
#burst_trades #HFT #trading ...
Daily Wrap - Final Message: Daily Wrap up for 2026-11-06 - 4557 events.
#burst_trades #HFT #trading ...
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-reports-third-quarter-2026-financial-results-pjtf5uvngs37.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-reports-third-quarter-2026-financial-results-pjtf5uvngs37.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-to-participate-in-the-stifel-2026-healthcare-7gwbz794ngfa.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-to-participate-in-the-stifel-2026-healthcare-7gwbz794ngfa.html?utm_source=stocktitan-bluesky&utm_medium=social
• Holder: Jennison Associates
• Stake: 6.7% → 7.7% (about $146M)
• Shares: 960,619 → 1,101,652
• Filed: Oct 28 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks
• Holder: Jennison Associates
• Stake: 6.7% → 7.7% (about $146M)
• Shares: 960,619 → 1,101,652
• Filed: Oct 28 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks
FDA accepts Palvella's QTORIN rapamycin NDA with Priority Review; PDUFA date Feb 28, 2027
#SEC #stocks #investing #PVLA #Regulatory
🔗 secwatch.observer
FDA accepts Palvella's QTORIN rapamycin NDA with Priority Review; PDUFA date Feb 28, 2027
#SEC #stocks #investing #PVLA #Regulatory
🔗 secwatch.observer
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-to-host-third-quarter-2026-financial-results-ndt1ur3dj8vl.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PVLA/palvella-therapeutics-to-host-third-quarter-2026-financial-results-ndt1ur3dj8vl.html?utm_source=stocktitan-bluesky&utm_medium=social
Priority Review Granted - QTORIN Rapamycin NDA
FDA granted Priority Review to the QTORIN rapamycin NDA for microcystic lymphatic malformations, with a PDUFA date of February 28, 2027.
https://biostock.app/symbols/PVLA
Priority Review Granted - QTORIN Rapamycin NDA
FDA granted Priority Review to the QTORIN rapamycin NDA for microcystic lymphatic malformations, with a PDUFA date of February 28, 2027.
https://biostock.app/symbols/PVLA
On October 28, 2026, Palvella Therapeutics, Inc. issued a press release announcing that the U.S. Food and Drug Administration has accepted for filing and granted Priority Review to the Company’s New Drug Application for QTORINTM 3.9% rapamycin anhydrous gel for the treatment of microcysti...
On October 28, 2026, Palvella Therapeutics, Inc. issued a press release announcing that the U.S. Food and Drug Administration has accepted for filing and granted Priority Review to the Company’s New Drug Application for QTORINTM 3.9% rapamycin anhydrous gel for the treatment of microcysti...
https://www.stocktitan.net/news/PVLA/palvella-announces-fda-acceptance-and-priority-review-of-qtorintm-fvgs1lktq1wv.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/PVLA/palvella-announces-fda-acceptance-and-priority-review-of-qtorintm-fvgs1lktq1wv.html?utm_source=stocktitan-bluesky&utm_medium=social
SOLD: 2,043 shares @ $123.62
Total: $253K
Filed Oct 20, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/PVLA
#InsiderTrading #PVLA #StockMarket
SOLD: 2,043 shares @ $123.62
Total: $253K
Filed Oct 20, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/PVLA
#InsiderTrading #PVLA #StockMarket
SOLD: 1,663 shares @ $125.16
Total: $208K
Filed Oct 20, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/PVLA
#InsiderTrading #PVLA #StockMarket
SOLD: 1,663 shares @ $125.16
Total: $208K
Filed Oct 20, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/PVLA
#InsiderTrading #PVLA #StockMarket